Capitol Hill Report
Advocacy
Read the Academy's bi-weekly update on legislative and regulatory advocacy for neurology.
June 22, 2026
Huge milestone for prior authorization bill
We’ve got your back on Capitol Hill—and we’re in overdrive advocating for you and your patients. Capitol Hill Report is your source for all things neurology advocacy, including this exciting update on prior authorization reform. Let us know if your practice, research, or patients are affected by recent policy changes.
Issue in focus
The Improving Seniors' Timely Access to Care Act (H.R. 3514) is a longstanding Âé¶¹´«Ã½Ó³» advocacy priority. In the last Congress, the legislation garnered overwhelming bipartisan support, including unanimous passage in the House of Representatives.
This bill would make significant improvements to the prior authorization process in Medicare Advantage (MA), reducing administrative burdens on physicians and helping ensure patients receive timely access to medically necessary care.
The legislation would require MA plans to adopt a standardized electronic prior authorization system, creating a more efficient and streamlined process for submitting and reviewing requests. It would also increase transparency by requiring MA plans to provide greater information about their prior authorization requirements and utilization, helping patients and providers better understand coverage decisions.
In addition, the bill would clarify the authority of the US Department of Health and Human Services (HHS) to establish timelines for prior authorization determinations, including expedited requests and the future implementation of real-time decisions for routinely approved items and services.
Finally, the bill would require HHS and other federal agencies to report to Congress on oversight efforts, program integrity measures, and additional opportunities to improve the electronic prior authorization process. Together, these reforms would modernize prior authorization in MA plans, improve efficiency for providers, and help ensure seniors can access the care they need when they need it.
This year, thanks in part to strong grassroots advocacy from Âé¶¹´«Ã½Ó³» members, the legislation has reached 290 bipartisan House cosponsors and now qualifies for the Consensus Calendar, a fast-track process reserved for broadly supported legislation. Placement on the Consensus Calendar gives the House Ways and Means Committee 25 legislative days to act on the bill. If the committee does not advance the legislation within that timeframe, the bill sponsor may pursue a vote by the full House.
This milestone reflects growing momentum for prior authorization reform and brings this important legislation one step closer to becoming law. Thank you to all the Âé¶¹´«Ã½Ó³» members who responded to our Action Alert and contacted their members of Congress—you made this progress possible. Watch for future advocacy opportunities with us to keep the momentum going!
Latest advocacy news
Âé¶¹´«Ã½Ó³» responds to FDA request for information on drug repurposing
The Âé¶¹´«Ã½Ó³» has submitted a response to a recently released request for information from the Food and Drug Administration (FDA) concerning priorities for drug repurposing for unmet medical needs. The FDA has identified neurodegenerative and rare disease as areas for prioritization. The Âé¶¹´«Ã½Ó³»’s comments are aimed at promoting evidence-based patient access to therapy.
Âé¶¹´«Ã½Ó³» joins with coalition partners in support of prior authorization reform
The Âé¶¹´«Ã½Ó³» joined with partners from across the house of medicine last week in support of proposed guardrails on the implementation of prior authorization policies for drugs. The coalition effort follows on the Âé¶¹´«Ã½Ó³»’s recent submission of organizational comments and urges the Centers for Medicare & Medicaid Services to move forward with key reforms aimed at reducing administrative burdens associated with medication-related prior authorization policies.
What we're reading
-
Democrats unveil drug pricing policy roadmap ahead of midterms |
-
How sick is sick enough? New Medicaid work rule worries patient advocates, states |
-
Backed by Threat of Clawbacks, Feds Wield Tight Grip on $50B Rural Health Fund |
Past Capitol Hill Reports
2026
- June 8: Sweeping changes proposed for research funding process
- May 25: Our efforts to address prior authorization burden
- May 11: Senators receive Wiesman Award for neurology leadership
- April 20: Protecting neuroscience research in FY2027
- April 6: Connect with BrainPAC at the Annual Meeting
- March 23: Appropriations season for FY 2027
- March 9: Our 2026 advocacy priorities
- February 23: Standing up for neurology in Washington
- February 9: State advocacy update
- January 26: Proposed funding package includes major wins
- January 12: NINDS director’s sudden departure
2025
- December 22: A year of advocacy
- December 8: Member elevates the voice of neurology at AMA
- November 24: Government funding update
- November 10: 2026 Medicare Physician Fee Schedule final rule
- October 20: Joint forum on neuroscience research
- October 6: How the government shutdown affects you
- September 22: Looming government shutdown
- September 8: An important BrainPAC update
- August 25: State advocates unite on health policy challenges
- August 11: 140+ Âé¶¹´«Ã½Ó³» members join Neurology off the Hill
- July 21: What’s in the Medicare fee schedule proposal?
- July 7: What’s in the big reconciliation bill?
- June 23: Âé¶¹´«Ã½Ó³» member highlight
- June 9: Why member advocacy is ‘mission-critical’
- May 27: House passes reconciliation bill
- May 12: President's proposed budget
- April 21: The state of Medicare and Medicaid
- April 7: Âé¶¹´«Ã½Ó³» president highlights advocacy
- March 24: There’s a new chance to support neuroscience
- March 10: March 14 government funding deadline
- February 24: Âé¶¹´«Ã½Ó³» members meet in Washington, DC
- February 11: Executive branch update
- January 20: New Congress, new plan
- January 6: Congress fails to address physician priorities
2024
- December 9: Key year-end issues
- November 25: Extending telehealth flexibilities
- November 11: What could fix physician reimbursement?
- October 21: Congressional lame-duck session
- October 7: Your advocacy impact
- September 23: Brain health for all!
- September 9: Âé¶¹´«Ã½Ó³» comments on Medicare Fee Schedule
- August 26: Physicians are essential in local advocacy
- August 12: Ask Congress to take action for telehealth
- July 22: Urge Congress to prevent proposed cut
- July 8: Advocate for neurology from your home state!
- June 24: Crucial prior authorization bill introduced in Congress
- June 10: Senate group to discuss Medicare payment reform
- May 20: 30 years of Conrad 30
- May 6: Lobbyist for a Day
- April 22: Congress considers access to care
- April 8: Âé¶¹´«Ã½Ó³» recommends more transparency in Medicare Advantage
- March 25: Âé¶¹´«Ã½Ó³» identifies top advocacy priorities
- March 11: Congress acts on Medicare cuts
- February 26: Could your advocacy go even further at the state level?
- February 12: Neurology on the Hill preview
- January 22: Medicare reimbursement update
- January 8: 2023 Advocacy year in review
2023
- December 11: Take Action to Prevent Damaging Reimbursement Cuts!
- November 20: Âé¶¹´«Ã½Ó³» Members Provide Perspective at AMA Meeting
- November 6: How Will the CMS Fee Schedule Affect You?
- October 23: Reps Hear Proposal to Cut 'Red Tape'
- October 9: Participant Goes from Training to Testimony
- September 25: Âé¶¹´«Ã½Ó³» Leaders Take the Hill
- September 11: Âé¶¹´«Ã½Ó³» Submits Comments on 2024 Medicare Physician Fee Schedule
- August 21: Proposed Code Will Help CMS Value Cognitive Care Services
- August 7: Reinforcements Are on the Way!
- July 24: Âé¶¹´«Ã½Ó³» President Elect Testifies on New Alzheimer's Treatments
- July 10: FDA Approves Lecanemab for Alzheimer's Disease
- June 26: MACRA, Prior Authorization, and AMA Resolutions
- June 12: Debt Limit Deal Affects Dollars for Research
- May 22: Want Step Therapy Reform? Please Step Forward!
- May 8: Act Now to Protect Veteran Care, Medicare Reimbursement
- April 24: Do You Know the Âé¶¹´«Ã½Ó³»'s 2023 Advocacy Priority Issues?
- April 10: Âé¶¹´«Ã½Ó³» Responds to Health Workforce Crisis Inquiry
- March 20: Working with CMS on Monoclonal Antibodies Coverage
- March 6: Support Your 180 Colleagues Now Advocating in DC
- February 20: Capitol Hill Report: Âé¶¹´«Ã½Ó³» Addresses National, State Health Care Issues
- February 6: Confronting Prior Authorization Burden, End of PHE
- January 23: Advisory Committee Supports Medicare Reimbursement Increases
- January 9: Top Âé¶¹´«Ã½Ó³» Advocacy Successes in 2022